TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/26/2024
Back to search
Official data from USPTO
DXT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/31/2024
Trademark type
Word
Nice classes
5, 9, 42
Filing date
04/12/2022
Registration date
12/19/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/19/2023
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
IT
Examiner
YOO, JEANE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DOMPE' FARMACEUTICI S.P.A.
Representatives
Theodore R. Remaklus Thompson Hine LLP
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceutical preparations; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of rare ocular disorders or diseases; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold preparations; pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of rare tissue and organ transplantation-related diseases and conditions; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparationsanticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparationsan analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devicesblood-related medical and laboratory devicesblood-related software and technologyblood-related medical device and data management systems for peripheral nervous system; pharmaceutical preparations for the treatment of rare diabetes-related conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases; pharmaceutical preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparationsan analgesic for human consumption taken orally; disinfectants for hygiene purposes; none of the foregoing for use with blood-related cell processing devicesblood-related medical and laboratory devicesblood-related software and technologyblood-related medical device and data management systems
Class 9
Downloadable computer software for use in identifying new drugs; downloadable computer software for use by doctors and other medical professionals in capturingtrackingreportinganalyzing health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable computer application software for mobile phonessoftware for use in identifying new drugs; downloadable computer software using artificial intelligence for use in identifying new drugs; none of the foregoing for use with blood-related cell processing devicesblood-related medical and laboratory devicesblood-related software and technologyblood-related medical device and data management systems
Class 42
Software as a service (SAAS) services featuring software using artificial intelligence for use in identifying new drugs; providing a website featuring non-downloadable software using artificial intelligence for use in identifying new drugs; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of virtual reality software for medical teachingnone of the foregoing for use with blood-related cell processing devicesblood-related medical and laboratory devicesblood-related software and technologyblood-related medical device and data management systems
Publications
History of USPTO decisions and trademark events.
30 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/26/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/26/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/26/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/23/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/29/2024
FIMP
FINAL DISPOSITION PROCESSED
03/29/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/19/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2023
PUBO
PUBLISHED FOR OPPOSITION
10/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/13/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/13/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2023
RFNT
REFUSAL PROCESSED BY IB
04/20/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2023
RFRR
REFUSAL PROCESSED BY MPU
03/29/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/04/2023
CNRT
NON-FINAL ACTION WRITTEN
02/03/2023
DOCK
ASSIGNED TO EXAMINER
01/30/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/08/2022
Continuous trademark protection
Get notified about every new filing that threatens DXT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.